In the latest issue, find out more about the benefits that
minocycline has shown to have on people living with early-onset
MS, and much more!
Be sure to read the latest edition of Progress Report, the MS Society of Canada’s biannual newsletter. It’s where you’ll find the latest information on the innovative research funded by your generosity.
In this issue, you’ll get breaking news about:
In this issue, you’ll also enjoy:
- How a 50-year-old antibiotic has emerged as a surprisingly effective MS treatment option, and why the MS community can benefit from it — starting now.
- The groundbreaking Canadian MS Progression Cohort study, which will observe a large group of people living with MS in order to better understand the signs, triggers, and process of MS progression over time.
- The first-ever FDA approved treatment for primary progressive MS, and much more.
Research in Action
Research in Action is a bulletin aimed to deliver the latest news on MS research taking place in communities across Canada, and around the world. In addition to breaking news, Research in Action will highlight the latest MS Updates, blog posts from Vice-President, Research Dr. Karen Lee, profiles of researchers and research volunteers, and important upcoming events in MS research.
To subscribe to Research in Action, click here and enter your email address where it says "Stay Updated".